NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Scope & Guideline

Illuminating the Pathways of Molecular Medicine

Introduction

Explore the comprehensive scope of NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1525-7770
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2000 to 2024
AbbreviationNUCLEOS NUCLEOT NUCL / Nucleosides Nucleotides Nucleic Acids
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS' focuses on the biochemical and molecular aspects of nucleosides, nucleotides, and nucleic acids with an emphasis on their implications in health, disease, and therapeutic applications. It serves as a platform for disseminating cutting-edge research that bridges molecular biology and medicinal chemistry.
  1. Genetic Polymorphisms and Disease Associations:
    Research frequently explores the associations between genetic polymorphisms in nucleic acid-related genes and various diseases, including cancer, metabolic disorders, and infectious diseases. This area aims to elucidate how these genetic variations impact disease susceptibility and progression.
  2. Nucleotide Metabolism and Therapeutics:
    The journal publishes studies on the metabolism of nucleotides and their role in therapeutic contexts, particularly in cancer treatment and drug development. This includes investigations into nucleoside analogs and their mechanisms of action.
  3. Molecular Biology Techniques and Innovations:
    There is a strong emphasis on methodological advancements in molecular biology techniques, including the synthesis of nucleoside derivatives, oligonucleotide synthesis, and innovative analytical methods such as mass spectrometry and bioinformatics.
  4. MicroRNAs and Long Non-Coding RNAs:
    The exploration of microRNAs and long non-coding RNAs in gene regulation, cancer biology, and their potential as biomarkers or therapeutic targets is a key focus area.
  5. Bioinformatics and Computational Biology:
    The journal features research that employs bioinformatics tools and computational modeling to understand nucleic acid interactions, predict gene functions, and analyze large genomic datasets.
The journal has seen a notable evolution in its thematic focus, reflecting broader trends in biomedical research. Emerging themes highlight the journal's adaptability to current scientific challenges and innovations.
  1. COVID-19 and Infectious Disease Research:
    The impact of the COVID-19 pandemic has led to a surge in research related to genetic susceptibility, antiviral treatments, and the role of nucleotides in immune responses against infections.
  2. Cancer Genomics and Precision Medicine:
    There is an increasing emphasis on cancer genomics, particularly studies linking genetic variations and tumor biology to precision medicine approaches, which tailor treatments based on individual genetic profiles.
  3. Functional Role of Non-Coding RNAs:
    Research into the functional roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is gaining prominence, with implications for cancer biology, gene regulation, and therapeutic applications.
  4. Metabolomics and Nucleotide Profiling:
    Emerging studies are focusing on metabolomic profiling of nucleotides and their metabolites in various biological contexts, providing insights into metabolic pathways and disease states.
  5. Advanced Drug Delivery Systems:
    Research on innovative drug delivery systems, particularly those utilizing nucleic acids for targeted therapy, is on the rise, reflecting the growing interest in nucleic acid-based therapeutics.

Declining or Waning

While the journal maintains a robust publication record, certain themes have shown a decline in prevalence over the years. This may reflect shifting research priorities or advancements in methodology that render previous approaches less relevant.
  1. Traditional Antiviral Agents:
    Research focused on classical antiviral nucleoside analogs has decreased, possibly due to the rise of novel therapeutic approaches like RNA interference and CRISPR technology, which offer alternative strategies for viral infections.
  2. Basic Nucleotide Biochemistry:
    Studies that solely emphasize the biochemistry of nucleotides without clinical or therapeutic implications have waned. The journal's focus has increasingly shifted towards applications and translational research.
  3. Plant-Based Nucleotide Sources:
    Research into naturally occurring nucleosides and their extraction from plant sources has become less prominent, as synthetic and semi-synthetic approaches gain more attention for their efficiency and specificity.

Similar Journals

ACTA BIOCHIMICA POLONICA

Exploring the Frontiers of Biochemical Knowledge
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Genetic Testing and Molecular Biomarkers

Illuminating Pathways in Genetic Testing and Biomarker Discovery.
Publisher: MARY ANN LIEBERT, INCISSN: 1945-0265Frequency: 12 issues/year

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

AIMS Molecular Science

Unlocking Innovations in Molecular Science
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2372-0301Frequency: 4 issues/year

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

IUBMB LIFE

Advancing the Frontiers of Life Sciences
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

CELLULAR SIGNALLING

Unlocking the Secrets of Signal Transduction
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

BIOCHEMICAL GENETICS

Innovating the Understanding of Genetic Mechanisms
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0006-2928Frequency: 6 issues/year

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Navigating the Complexities of Human Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Cancer Cell International

Connecting Researchers to Combat Cancer
Publisher: BMCISSN: Frequency: 1 issue/year

Cancer Cell International, published by BMC, is a transformative open-access journal established in 2001, dedicated to advancing the field of oncology and cancer research. With its ISSN number not specified and an E-ISSN of 1475-2867, the journal proudly operates from the United Kingdom, located at CAMPUS, 4 Crinan St, London N1 9XW, England. Renowned for its rigorous peer-review process, Cancer Cell International has made significant strides, securing a Q2 ranking in Cancer Research and Q1 rankings in both Genetics and Oncology as of 2023. It ranks impressively in Scopus, featuring in the top quintile of Genetics (#37/347) and Oncology (#52/404), indicating its importance within the scientific community. The journal's broad scope caters to a diverse array of topics within cancer biology, making it an invaluable resource for researchers, professionals, and students seeking to stay at the forefront of cancer science. With a commitment to disseminating high-quality research, Cancer Cell International invites scholars to explore innovative findings and contribute to the collective effort of combating cancer.

Non-Coding RNA

Advancing Knowledge in Non-Coding RNA Research
Publisher: MDPIISSN: Frequency: 6 issues/year

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

MOLECULAR BIOLOGY

Advancing the Frontiers of Molecular Discovery
Publisher: PLEIADES PUBLISHING INCISSN: 0026-8933Frequency: 6 issues/year

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.